News
(Reuters) -Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney ...
Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...
The Canadian Press on MSN3d
Health Canada approves Ozempic to reduce kidney deterioration in people with diabetes
TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes ...
Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, to reduce the risk of kidney failure and ...
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...
Novo Nordisk announced today that Ozempic® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly ...
The Canadian Press on MSN3d
Quebec City using artificial intelligence to manage traffic, reduce congestion
According to Google Canada, Quebec City is the first municipality in the country to partner with the web giant's Green Light ...
The Canadian Press on MSN3d
Quebec workers could face same fate as Air Canada flight attendants, union leaders say
The law gives Quebec's labour minister the power to end a labour dispute by imposing arbitration when the strike or lockout is deemed likely to cause serious harm to the public.
Stocktwits on MSN3d
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
Danish drugmaker Novo Nordisk (NVO) on Tuesday said that its blockbuster drug Ozempic is now approved in Canada to reduce the risk of kidney function decline, end-stage kidney disease, and ...
Drugmaker Sandoz could offer unbranded weight-loss drugs at an up to 70 per cent discount to the branded versions in Canada when patents start to expire there next year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback